Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 10/20 | 0.61 |
| ▸ | CNR1 | P21554 | 9/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | ABHD12 | Q8N2K0 | 1/20 | 0.41 |
| ▸ | RGS4 | P49798 | 1/20 | 0.39 |
| ▸ | RGS8 | P57771 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2745641 | 0.90 | CNR2 (0.64) | CNR2CNR1L3MBTL1ALDH1A1KDM4E | |
| SCHEMBL11922842 | 0.86 | CNR2 (0.67) | CNR2CNR1ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL5514468 | 0.86 | CNR2 (0.67) | CNR2CNR1L3MBTL1ALDH1A1KDM4E | |
| SCHEMBL5509529 | 0.83 | CNR2 (0.66) | CNR2CNR1FAAHABHD12 | |
| SCHEMBL14865368 | 0.83 | CNR2 (0.63) | CNR2CNR1L3MBTL1ALDH1A1KDM4E | |
| SCHEMBL5516311 | 0.79 | CNR2 (0.61) | CNR2CNR1FAAHABHD12 | |
| SCHEMBL2746202 | 0.79 | CNR2 (0.60) | CNR2CNR1L3MBTL1FAAHKMT2A | |
| SCHEMBL5516384 | 0.79 | CNR2 (0.60) | CNR2CNR1L3MBTL1FAAHKMT2A | |
| SCHEMBL5510356 | 0.78 | CNR2 (0.52) | CNR2CNR1ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL5517486 | 0.78 | CNR2 (0.57) | CNR2CNR1FAAHABHD12KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080103139-A1 | 3-Carbamoyl-2-Pyridone Derivative | SHIONOGI & CO. LTD. (JP) | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103139-A1 | 3-Carbamoyl-2-Pyridone Derivative | CNR1, CNR2, HRH4 | CNR2 2/4885CNR1 1/4885L3MBTL1 3878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.